Previous close | 31.13 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 347 |
Market cap | 72.978M |
Beta (5Y monthly) | 1.53 |
PE ratio (TTM) | 0.54 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Q1 2024 Abcellera Biologics Inc Earnings Call
Explore key insights from Aramark's impressive second quarter performance, marked by historic revenue highs and strategic expansions.
While the top- and bottom-line numbers for Aramark (ARMK) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.